Distinct immune responses in people living with HIV following SARS-CoV-2 recovery
Anton M. Sholukh(Fred Hutch Cancer Center), Xiaoying Shen(University of California, Los Angeles), Kristen W. Cohen(Moderna Therapeutics (United States)), Taylor Keyes(Duke University), Lakshmanane Premkumar(University of North Carolina at Chapel Hill), Lu Zhang, Caroline Brackett(Duke University), Daniel J. Schuster(Duke University), Adam Zalaquett(Duke University), Georgia D. Tomaras(National Institutes of Health), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Shuying Sue Li(Fred Hutch Cancer Center), Stephen De Rosa(Fred Hutch Cancer Center), Guido Ferrari(Duke University), Sherry Stanfield-Oakley(Duke University), Dieter Mielke(Duke University), Martina S. Wesley, Lawrence Corey(Fred Hutch Cancer Center), Nicole L. Yates(Duke University), Brooke Dunn(Duke University), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nathan Eisel, Ollivier Hyrien(Fred Hutch Cancer Center), Xiaohong Li(Central South University), Jiani Hu(East China Normal University), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kelly E. Seaton(International Vaccine Institute), M J McElrath(Fred Hutch Cancer Center), Russell St. Germain(Fred Hutch Cancer Center)
Cited by 0
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k
Microplastic and mesoplastic pollution in farmland soils in suburbs of Shanghai, China
|Environmental Pollution|2018|1.3k